Purchase Order 75N92025P00395

Award Date 9/22/25
Potential Completion Date 11/22/25
Potential Value $24K
Awardee
Ampseq LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $24,840 firm fixed price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency under the U.S. Department of Health and Human Services, to Ampseq LLC, a for-profit limited liability company owned by Asian-Pacific Americans. The purpose of the contract is to perform library preparation and sequencing of 4 10X Multiome libraries to elucidate signaling in CAR T cells in order to optimize them for therapeutic purposes. The contract has an ultimate...
This is a federal contract award by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Government Scientific Source Inc., a for-profit organization based in Reston, Virginia, to provide 10X Genomics single cell sequencing library preparation reagents. The contract has a firm fixed price of $43,426.50 and a period of performance that runs through October 5, 2025. The contract was awarded...
This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Government Scientific Source Inc. for single-cell RNA sequencing kits. The $37,366.64 firm-fixed-price delivery order contract is awarded under the Multiple Award Schedule (MAS) contract vehicle and has an ultimate completion date of August 18, 2025. The contract supports the NHLBI Young Lab's analysis of expression levels of various factors in...
This is a $16,000 firm-fixed-price purchase order awarded by the National Cancer Institute, a civilian federal agency, to Ampseq LLC, a for-profit, Asian-Pacific American-owned limited liability company. The contract is for Ampseq to provide Olink technology, which combines specificity and scalability to enable high-throughput, multiplex protein biomarker analysis. This service will help the agency obtain a next-generation proteomics platform using minimal sample volumes. The contract has an...
This is a $24,000.00 firm-fixed-price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to Ampseq LLC, a for-profit limited liability company owned by Asian-Pacific Americans. The contract is for mRNA sequencing services and is set aside for small businesses. The period of performance runs from the award date of September 1, 2025 through the ultimate completion date of August 31, 2026. The place of performance is Bethesda,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
This contract, awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute, is for the purchase of single cell ribonucleic acid (RNA) sequencing of adaptive immune cells and T and B cell receptor repertoire analysis. The contract has a firm fixed price of $29,666.00 and was awarded on August 5, 2022 to Azenta US Inc., doing business as Brooks Life Sciences Inc. This award does not have a set-aside designation. Azenta US Inc. is a...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a firm fixed-price delivery order worth $18,145.37 to Illumina, Inc. for DNA sequencing library preparation kits. This order is part of a broader Indefinite Delivery Contract between Illumina and the Department of the Navy Bureau of Medicine and Surgery, valued up to $3.3 million, to support nucleic acid sequencing needs at the Naval Medical Research Center. The contract...
The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $19,337.17 delivery order contract to Illumina, Inc. of San Diego, California. The contract is for a firm fixed price and requires the prime contractor to provide reagent kits to the DNA Sequencing Core in order to prepare RNA sequencing libraries for sequencing from August 29, 2023 through September 28, 2023. No subcontractors or set aside designations...

The National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) awarded a $24,200 firm-fixed-price purchase order to Ampseq LLC, a for-profit, Asian-Pacific American-owned limited liability company, to provide library preparation and sequencing of 5' single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) libraries. The purpose is to elucidate signaling in chimeric antigen receptor (CAR) T cells to optimize therapeutic approaches. This contract has no set-aside designation and is scheduled for completion by November 22, 2025.

Generated 9/24/25, 10:52 AM